Selenium and impaired physical function in US and Spanish older adults

Background: Selenium (Se) is a trace element with a narrow safety margin. Objectives: To evaluate the cross-sectional and longitudinal dose-response association between Se exposure and measures of impaired physical function and disability in older adults. Design: NHANES 2011–2014 cross-sectional (US, n = 1733, age ≥60 years) and Seniors-ENRICA-2 2017–2019 cross-sectional and longitudinal (Spain, n = 2548 and 1741, respectively, age ≥65 years) data were analyzed. Whole blood and serum Se levels were measured using inductively coupled plasma-mass spectrometry. Lowerextremity performance was assessed with the Short Physical Performance Battery, and muscle weakness with a dynamometer. Incident mobility and agility limitations, and disability in instrumental activities of daily living (IADL) were ascertained with standardized questionnaires. Analyses were adjusted for relevant confounders, including physical activity. Results across studies were pooled using random-effects meta-analysis. Results: Meta-analyzed odds ratios (95% confidence interval) per log2 increase in whole blood Se were 0.54 (0.32; 0.76) for weakness, 0.59 (0.34; 0.83) for impaired lower-extremity performance, 0.48 (0.31; 0.68) for mobility limitations, 0.71 (0.45; 0.97) for agility limitations, and 0.34 (0.12; 0.56) for disability in at least one IADL. Analyses for serum Se in NHANES showed similar results. Findings suggest the inverse association with grip strength is progressive below 140 μg/L (p-value for non-linear trend in the Seniors-ENRICA-2 study = 0.13), and above 140 μg/L (p-value for non-linear trend in NHANES = 0.11). In the Seniors-ENRICA-2 cohort, with a 2.2 year follow-up period, a doubling in baseline Se levels were associated with a lower incidence of weakness [odds ratio (95% confidence interval): 0.45 (0.22; 0.91)], impaired lower-extremity performance [0.63 (0.32; 1.23)], mobility [0.43 (0.21; 0.91)] and agility [0.38 (0.18; 0.78)] limitations. Discussion: In US and Spanish older adults, Se concentrations were inversely associated with physical function limitations. Further studies are needed to elucidate underlying mechanisms.Instituto de Salud Carlos III European Commission PI18/287 16/609State Secretary of R + D + I PID2019-108973RB-C21/C22European Social Fund (ESF) European Commissio

Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region.

In the past 5-10 years, Venezuela has faced a severe economic crisis, precipitated by political instability and declining oil revenue. Public health provision has been affected particularly. In this Review, we assess the impact of Venezuela's health-care crisis on vector-borne diseases, and the spillover into neighbouring countries. Between 2000 and 2015, Venezuela witnessed a 359% increase in malaria cases, followed by a 71% increase in 2017 (411 586 cases) compared with 2016 (240 613). Neighbouring countries, such as Brazil, have reported an escalating trend of imported malaria cases from Venezuela, from 1538 in 2014 to 3129 in 2017. In Venezuela, active Chagas disease transmission has been reported, with seroprevalence in children (<10 years), estimated to be as high as 12·5% in one community tested (n=64). Dengue incidence increased by more than four times between 1990 and 2016. The estimated incidence of chikungunya during its epidemic peak is 6975 cases per 100 000 people and that of Zika virus is 2057 cases per 100 000 people. The re-emergence of many vector-borne diseases represents a public health crisis in Venezuela and has the possibility of severely undermining regional disease elimination efforts. National, regional, and global authorities must take action to address these worsening epidemics and prevent their expansion beyond Venezuelan borders

Técnica DHS mínimamente invasiva: menor tiempo quirúrgico con similares resultados en el postoperatorio inmediato respecto al DHS convencional. Estudio retrospectivo de cohortes / Minimally invasive dynamic hip screw technique: shorter surgical time with similar post-surgical results compared to conventional DHS technique. A retrospective cohort study

Objetivos: El tratamiento de fracturas pertrocantéreas con DHS mediante técnica mínimamente invasiva (MIDHS) ha mostrado resultados superiores a la técnica convencional (CDHS) en estudios previos. El presente estudio pretende determinar si existen diferencias en requerimientos transfusionales, morbilidad, estancia hospitalaria y en el coste asociado, a partir de un análisis retrospectivo de 2 cohortes. Material y método: Estudio de cohortes en 80 pacientes con fracturas intertrocantéreas de fémur (31-A1 y 31-A2.1) tratados con implante DHS entre julio de 2005 y septiembre de 2007: 40 de ellos con la técnica convencional y 40 de ellos con técnica MIDHS. Resultados: No se observaron diferencias estadísticamente significativas ni en la pérdida sanguínea, ni en requerimientos transfusionales, ni en morbilidad. La estancia hospitalaria en el grupo MIDHS fue 1,3 días menor, con un coste directo de 3,063 por caso, inferior al grupo CDHS, aunque sin significación estadística (p = 0,3). La duración de la intervención fue menor en el grupo MIDHS: 49,3 versus 78,8 min (p = 0,0001). Discusión: Contrariamente a lo publicado en estudios previos, en el presente estudio la técnica MIDHS no ha mostrado ventajas excepto por requerir un menor tiempo para realizar la técnica. Consideramos que la técnica MIDHS podría ayudar en mejorar la productividad y eficiencia en el uso de quirófano

Técnica DHS mínimamente invasiva: menor tiempo quirúrgico con similares resultados en el postoperatorio inmediato respecto al DHS convencional. Estudio retrospectivo de cohortes / Minimally invasive dynamic hip screw technique: shorter surgical time with similar post-surgical results compared to conventional DHS technique. A retrospective cohort study

Objetivos: El tratamiento de fracturas pertrocantéreas con DHS mediante técnica mínimamente invasiva (MIDHS) ha mostrado resultados superiores a la técnica convencional (CDHS) en estudios previos. El presente estudio pretende determinar si existen diferencias en requerimientos transfusionales, morbilidad, estancia hospitalaria y en el coste asociado, a partir de un análisis retrospectivo de 2 cohortes. Material y método: Estudio de cohortes en 80 pacientes con fracturas intertrocantéreas de fémur (31-A1 y 31-A2.1) tratados con implante DHS entre julio de 2005 y septiembre de 2007: 40 de ellos con la técnica convencional y 40 de ellos con técnica MIDHS. Resultados: No se observaron diferencias estadísticamente significativas ni en la pérdida sanguínea, ni en requerimientos transfusionales, ni en morbilidad. La estancia hospitalaria en el grupo MIDHS fue 1,3 días menor, con un coste directo de 3,063 por caso, inferior al grupo CDHS, aunque sin significación estadística (p = 0,3). La duración de la intervención fue menor en el grupo MIDHS: 49,3 versus 78,8 min (p = 0,0001). Discusión: Contrariamente a lo publicado en estudios previos, en el presente estudio la técnica MIDHS no ha mostrado ventajas excepto por requerir un menor tiempo para realizar la técnica. Consideramos que la técnica MIDHS podría ayudar en mejorar la productividad y eficiencia en el uso de quirófano

Risk of diabetes in patients with sleep apnea: comparison of surgery versus CPAP in a long-term follow-up study

Abstract This study aimed to obtain a comprehensive view of the risk of developing diabetes in patients with obstructive sleep apnea (OSA) and to compare this risk between patients receiving continuous positive airway pressure (CPAP) therapy versus upper airway surgery (UAS). We used local and the global-scale federated data research network TriNetX to obtain access to electronic medical records, including those for patients diagnosed with OSA, from health-care organizations (HCOs) worldwide. Using propensity score matching and the score-matched analyses of data for 5 years of follow-up, we found that patients who had undergone UAS had a lower risk of developing diabetes than those who used CPAP (risk ratio 0.415, 95% confidence interval (CI) 0.349–0.493). The risk for newly diagnosed diabetes patients showed a similar pattern (hazard ratio 0.382; 95% CI 0.317–0.459). Both therapies seem to protect against diabetes (Risk 0.081 after UAS vs. 0.195 after CPAP). Analysis of the large data sets collected from HCOs in Europe and globally lead us to conclude that, in patients with OSA, UAS can prevent the development of diabetes better than CPAP. Graphical Abstrac

EP329 / #1049 Intratumoral Hemorrhage In Pediatric Low-Grade-Gliomas: An International Case Series

Background and Aims: Pediatric low-grade gliomas (PLGG) are grade I and II WHO tumors. Intratumoral hemorrhage is a common complication (up to 8-20%), not well reported in the literature. It can happen at diagnosis, treatment, or follow-up. We have collected an International cohort of PLGG which developed an intratumoral hemorrhage. Methods: International, multicentric, observational, descriptive and retrospective analysis of 28 patients with a PLGG who suffered an intratumoral hemorrhage. We gathered data on demographic characteristics, histology, molecular findings, treatment received, and information related to the hemorrhagic event. Results: Twenty-eight patients were enrolled onto the study. Median age at tumor diagnosis was 10.1 years (range, 0.4 to 17.5 years). Three patients (10.7%) had a cancer predisposition syndrome (2 Neurofibromatosis type 1 and 1 Noonan syndrome). Most frequent histological subtypes: pilocytic astrocytoma (67.8%), pleomorphic xantoastrocytoma (10.7%) and pilomyxoid astrocytoma (7%). The most common locations: hypothalamic-chiasmatic (32.1%) and posterior fossa (25%). BRAF status was available in 16 patients (4 had a KIAA1549BRAF fusion and 2 a BRAFV600E mutation). NGS was performed in 10 patients, four of them had an FGFR alteration. Regarding therapy, all patients had initial surgery, with 42.8% needing further surgeries. Seventeen patients (60.7%) received at least one chemotherapy regimen, and six patients (21.4%) received radiotherapy. Twenty-four patients (85.7%) had a spontaneous intratumoral hemorrhage; other etiologies were post-traumatic (10.7%) and post-surgical (3.6%). In thirteen patients (46.4%), the hemorrhages occurred at the time of diagnosis. The main treatment strategies were surgery and observation (39.2% each group). Two patients (7.1%) died because of the bleeding event. To date, 75% of the patients are alive, although 4 of them (14.2%) had a recurrence of their hemorrhage. Conclusions: Pediatric low grade gliomas are at risk of intratumoral hemorrhage, which occurs usually at diagnosis and spontaneously. Despite being a life-threatening situation, mortality and recurrence rates are low in these patients

Risk of diabetes in patients with sleep apnea: comparison of surgery versus CPAP in a long-term follow-up study

This study aimed to obtain a comprehensive view of the risk of developing diabetes in patients with obstructive sleep apnea (OSA) and to compare this risk between patients receiving continuous positive airway pressure (CPAP) therapy versus upper airway surgery (UAS). We used local and the global-scale federated data research network TriNetX to obtain access to electronic medical records, including those for patients diagnosed with OSA, from health-care organizations (HCOs) worldwide. Using propensity score matching and the score-matched analyses of data for 5 years of follow-up, we found that patients who had undergone UAS had a lower risk of developing diabetes than those who used CPAP (risk ratio 0.415, 95% confidence interval (CI) 0.349-0.493). The risk for newly diagnosed diabetes patients showed a similar pattern (hazard ratio 0.382; 95% CI 0.317-0.459). Both therapies seem to protect against diabetes (Risk 0.081 after UAS vs. 0.195 after CPAP). Analysis of the large data sets collected from HCOs in Europe and globally lead us to conclude that, in patients with OSA, UAS can prevent the development of diabetes better than CPAP

Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region

In the past 5–10 years, Venezuela has faced a severe economic crisis, precipitated by political instability and declining oil revenue. Public health provision has been affected particularly. In this Review, we assess the impact of Venezuela's health-care crisis on vector-borne diseases, and the spillover into neighbouring countries. Between 2000 and 2015, Venezuela witnessed a 359% increase in malaria cases, followed by a 71% increase in 2017 (411 586 cases) compared with 2016 (240 613). Neighbouring countries, such as Brazil, have reported an escalating trend of imported malaria cases from Venezuela, from 1538 in 2014 to 3129 in 2017. In Venezuela, active Chagas disease transmission has been reported, with seroprevalence in children ( less than 10 years), estimated to be as high as 12·5% in one community tested (n=64). Dengue incidence increased by more than four times between 1990 and 2016. The estimated incidence of chikungunya during its epidemic peak is 6975 cases per 100 000 people and that of Zika virus is 2057 cases per 100 000 people. The re-emergence of many vector-borne diseases represents a public health crisis in Venezuela and has the possibility of severely undermining regional disease elimination efforts. National, regional, and global authorities must take action to address these worsening epidemics and prevent their expansion beyond Venezuelan borders. © 2019 Elsevier Lt